🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

30.28 Gram(s) Serving Size
15 Servings
Amino acid/Protein Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

Calories
115.12 Kcal (6% DV)
Protein
24 Gram(s) (48% DV)
Total Carbohydrates
3 Gram(s) (1% DV)
Sugar
2 Gram(s)
Total Fat
1 Gram(s) (1.5% DV)
PERFORMANCE PROTEIN Proprietary Blend
Vitamin A
Vitamin C
Calcium
(25% DV)
Iron
(6% DV)

Label Claims — Verification

All Other
Structure/Function
All Other (98% of products) Structure/Function (89% of products) Nutrient (76% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Directions: Take 1 scoop pre or post workout mixed with water or milk.

⚠️ Warnings & Precautions

ALLERGEN STATEMENT: PRODUCED IN A FACILITY THAT USES PEANUT, TREE NUTS, AND EGG INGREDIENTS. CONTAINS MILK AND SOY (LECITHIN)

🧪 Formulation Notes

CONTAINS MILK AND SOY (LECITHIN)

115 CALORIES 5g BCAA 24g PROTEIN

Additional Information

SHREDZPROTEIN

PERFORMANCE BLEND

15 SERVINGS

MADE IN THE USA

Product Details

UPC / SKU 8 11207 02131 2
DSLD Entry Date 2014-04-25
Product Type Amino acid/Protein
Form Powder
Brand Shredz
DSLD ID 31964
Data Updated 2026-04-11

Research Evidence

46 Research Sources
55 Avg Quality Score
23 Meta Analysis
7 Systematic Review
7 Rct
4 Clinical Trial
2 Other
1 Guideline
1 Regulatory Source
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2025
B Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
Meta Analysis The Cochrane database of systematic reviews 2011
B Calcium and phosphorus supplementation of human milk for preterm infants
Systematic Review The Cochrane database of systematic reviews 2017
B Radiographic and clinical outcomes of silicate-substituted calcium phosphate (SiCaP) bone grafts in spinal fusion: Systematic review and meta-analysis
Meta Analysis Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2020
B ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium.
Guideline Clinical nutrition (Edinburgh, Scotland) 2018
B Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Annals of palliative medicine 2022
B Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia
Meta Analysis The Cochrane database of systematic reviews 2015
B The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of nephrology 2022
B Calcimimetics treatment strategy for serum calcium and phosphate management in patients with secondary hyperparathyroidism undergoing dialysis: A systematic review and meta-analysis of randomized studies
Meta Analysis Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2024
View all evidence for Phosphorus →

Compare Similar Products

View all Phosphorus products →